GlassScriptPhysician profile
Vincent S Scott
NPI 1699740027
$10,497.45
in general payments reported to CMS, 2019-2025
17 companies · $1,019 in 2025
The $1,019 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,308 · 2020: $213 · 2021: $71.14 · 2022: $829 · 2023: $3,242 · 2024: $1,816 · 2025: $1,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,143 · Travel and Lodging: $2,878 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,142.84 |
| Travel and Lodging | $2,878.26 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $4,252.74 | 2019-2025 | Altis, Saffron |
| Medtronic, INC. | $2,791.27 | 2022-2025 | Interstim, Altaviva |
| Boston Scientific Corporation | $1,725.91 | 2019-2023 | Solyx Sis System |
| Medtronic USA, INC. | $553.02 | 2019 | |
| Bluewind Medical | $370.07 | 2024 | Revi |
| Axonics, INC. | $303.38 | 2022-2024 | Axonics |
| Caldera Medical, INC | $193.41 | 2023 | Desara |
| Astellas Pharma US INC | $54.99 | 2023 | |
| Sumitomo Pharma America, INC. | $48.87 | 2023-2025 | Gemtesa |
| Conmed Corporation | $41.67 | 2021 | |
| Baxter Healthcare | $35.49 | 2024-2025 | Perclot |
| Abbvie INC. | $32.91 | 2024-2025 | |
| Janssen Biotech, INC. | $25.63 | 2025 | Erleada |
| Immunitybio, INC. | $23.37 | 2025 | |
| Novartis Pharmaceuticals Corporation | $16.15 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $14.29 | 2025 | Ally II Ups |
| Millicent US INC | $14.28 | 2024 | Intrarosa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.